|Tel:||+27 (0) 21 702 4299|
|Fax:||+27 (0) 21 702 4299|
CapeRay, previously known as African Medical Imaging, is a spin out company that has been set up to manufacture innovative imaging systems used in the diagnosis of various medical disorders.
The first application of our patented technology, known as the PantoScanner, is the diagnosis of breast cancer.
In the United States 18% of all cancer deaths are attributable to carcinoma of the breast while in Europe close to 350,000 new cases are detected every year. It is estimated that 1 in 4 of all South Africans will be affected by at least one cancer diagnosis in their lifetime, with carcinoma of the breast being the most common form of cancer in women. Clinical studies have shown that early detection has caused mortality rates to fall by 30 to 45%, and the earlier the detection the greater are the chances of survival. Our technology, which combines low dose digital X-rays with ultrasound, will be the most reliable method of early detection.
CapeRay is a spin out from the University of Cape Town (UCT) with previous financing coming from the Innovation Fund (South Africa) and the National Institutes of Health (USA). The current shareholders include UCT, the managing director Kit Vaughan, an employee trust, and the Industrial Development Corporation (South Africa) who have provided the third round of financing.
Product & services
Our first product will be the PantoScanner, an imaging system to detect